Long-term follow up of patients with Budd-Chiari syndrome and myeloproliferative disorders after liver transplantation
A Potthoff, D Attia, S Pischke, K Rifai, K Deterding, K Heiringhoff, J Klempnauer, CP Strassburg, MP Manns, MJ Bahr · Zeitschrift für Gastroenterologie · 2013 · Heft 01
Bibliografische Angaben
Zusammenfassung
Background: A considerable number of patients transplanted for Budd-Chiari syndrome suffer from myeloproliferative disorders (MPD). The impact of long-term immunosuppression on the clinical course of MPD is not well described. Methods: We analyzed the clinical course of 31 long-term survivors who received liver grafts for MPD-associated Budd-Chiari syndrome. Mean follow-up was 11.3 years, with 16 patients followed for more than 10 years after liver transplantation (OLT). All patients received standard immunosuppressive regime. Results: Three of the long-term survivors died from either recurrent thrombosis or ble…
